364 related articles for article (PubMed ID: 34000441)
1. Single-cell Analysis Technologies for Immuno-oncology Research: from Mechanistic Delineation to Biomarker Discovery.
Bai Z; Su G; Fan R
Genomics Proteomics Bioinformatics; 2021 Apr; 19(2):191-207. PubMed ID: 34000441
[TBL] [Abstract][Full Text] [Related]
2. Future perspectives in melanoma research : Meeting report from the "Melanoma Bridge". Napoli, December 1st-4th 2015.
Ascierto PA; Agarwala S; Botti G; Cesano A; Ciliberto G; Davies MA; Demaria S; Dummer R; Eggermont AM; Ferrone S; Fu YX; Gajewski TF; Garbe C; Huber V; Khleif S; Krauthammer M; Lo RS; Masucci G; Palmieri G; Postow M; Puzanov I; Silk A; Spranger S; Stroncek DF; Tarhini A; Taube JM; Testori A; Wang E; Wargo JA; Yee C; Zarour H; Zitvogel L; Fox BA; Mozzillo N; Marincola FM; Thurin M
J Transl Med; 2016 Nov; 14(1):313. PubMed ID: 27846884
[TBL] [Abstract][Full Text] [Related]
3. The Multi-Dimensional Biomarker Landscape in Cancer Immunotherapy.
Lee JY; Kannan B; Lim BY; Li Z; Lim AH; Loh JW; Ko TK; Ng CC; Chan JY
Int J Mol Sci; 2022 Jul; 23(14):. PubMed ID: 35887186
[TBL] [Abstract][Full Text] [Related]
4. Single-Cell Approaches to Profile the Response to Immune Checkpoint Inhibitors.
Gibellini L; De Biasi S; Porta C; Lo Tartaro D; Depenni R; Pellacani G; Sabbatini R; Cossarizza A
Front Immunol; 2020; 11():490. PubMed ID: 32265933
[TBL] [Abstract][Full Text] [Related]
5. Validation of biomarkers to predict response to immunotherapy in cancer: Volume I - pre-analytical and analytical validation.
Masucci GV; Cesano A; Hawtin R; Janetzki S; Zhang J; Kirsch I; Dobbin KK; Alvarez J; Robbins PB; Selvan SR; Streicher HZ; Butterfield LH; Thurin M
J Immunother Cancer; 2016; 4():76. PubMed ID: 27895917
[TBL] [Abstract][Full Text] [Related]
6. Single-Cell Multiplexed Proteomics on the IsoLight Resolves Cellular Functional Heterogeneity to Reveal Clinical Responses of Cancer Patients to Immunotherapies.
Liu D; Paczkowski P; Mackay S; Ng C; Zhou J
Methods Mol Biol; 2020; 2055():413-431. PubMed ID: 31502163
[TBL] [Abstract][Full Text] [Related]
7. Metabolic regulation of T cells in the tumor microenvironment by nutrient availability and diet.
Zhao S; Peralta RM; Avina-Ochoa N; Delgoffe GM; Kaech SM
Semin Immunol; 2021 Feb; 52():101485. PubMed ID: 34462190
[TBL] [Abstract][Full Text] [Related]
8. Cancer Immunotherapy - The Target is Precisely on The Cancer and Also Not.
Koo SL; Wang WW; Toh HC
Ann Acad Med Singap; 2018 Sep; 47(9):381-387. PubMed ID: 30324966
[TBL] [Abstract][Full Text] [Related]
9. Integrative insights and clinical applications of single-cell sequencing in cancer immunotherapy.
Liu Z; Li H; Dang Q; Weng S; Duo M; Lv J; Han X
Cell Mol Life Sci; 2022 Oct; 79(11):577. PubMed ID: 36316529
[TBL] [Abstract][Full Text] [Related]
10. Multi-Omics Profiling of the Tumor Microenvironment.
Van Oekelen O; Laganà A
Adv Exp Med Biol; 2022; 1361():283-326. PubMed ID: 35230695
[TBL] [Abstract][Full Text] [Related]
11. Applications of Single-Cell Omics in Tumor Immunology.
Liu J; Qu S; Zhang T; Gao Y; Shi H; Song K; Chen W; Yin W
Front Immunol; 2021; 12():697412. PubMed ID: 34177965
[TBL] [Abstract][Full Text] [Related]
12. The Role of Immunological Synapse in Predicting the Efficacy of Chimeric Antigen Receptor (CAR) Immunotherapy.
Liu D; Badeti S; Dotti G; Jiang JG; Wang H; Dermody J; Soteropoulos P; Streck D; Birge RB; Liu C
Cell Commun Signal; 2020 Aug; 18(1):134. PubMed ID: 32843053
[TBL] [Abstract][Full Text] [Related]
13. Single-cell RNA sequencing in cancer research: discovering novel biomarkers and therapeutic targets for immune checkpoint blockade.
Sun B; Xun Z; Zhang N; Liu K; Chen X; Zhao H
Cancer Cell Int; 2023 Dec; 23(1):313. PubMed ID: 38066642
[TBL] [Abstract][Full Text] [Related]
14. Recent advancements in tumour microenvironment landscaping for target selection and response prediction in immune checkpoint therapies achieved through spatial protein multiplexing analysis.
Andhari MD; Antoranz A; De Smet F; Bosisio FM
Int Rev Cell Mol Biol; 2024; 382():207-237. PubMed ID: 38225104
[TBL] [Abstract][Full Text] [Related]
15. Modeling the Tumor Microenvironment and Cancer Immunotherapy in Next-Generation Humanized Mice.
Chen A; Neuwirth I; Herndler-Brandstetter D
Cancers (Basel); 2023 May; 15(11):. PubMed ID: 37296949
[TBL] [Abstract][Full Text] [Related]
16. Insights Gained from Single-Cell Analysis of Immune Cells in the Tumor Microenvironment.
Ren X; Zhang L; Zhang Y; Li Z; Siemers N; Zhang Z
Annu Rev Immunol; 2021 Apr; 39():583-609. PubMed ID: 33637019
[TBL] [Abstract][Full Text] [Related]
17. Surmounting the obstacles that impede effective CAR T cell trafficking to solid tumors.
Donnadieu E; Dupré L; Pinho LG; Cotta-de-Almeida V
J Leukoc Biol; 2020 Oct; 108(4):1067-1079. PubMed ID: 32620049
[TBL] [Abstract][Full Text] [Related]
18. Rationally combining immunotherapies to improve efficacy of immune checkpoint blockade in solid tumors.
Dammeijer F; Lau SP; van Eijck CHJ; van der Burg SH; Aerts JGJV
Cytokine Growth Factor Rev; 2017 Aug; 36():5-15. PubMed ID: 28693973
[TBL] [Abstract][Full Text] [Related]
19. Association of Survival and Immune-Related Biomarkers With Immunotherapy in Patients With Non-Small Cell Lung Cancer: A Meta-analysis and Individual Patient-Level Analysis.
Yu Y; Zeng D; Ou Q; Liu S; Li A; Chen Y; Lin D; Gao Q; Zhou H; Liao W; Yao H
JAMA Netw Open; 2019 Jul; 2(7):e196879. PubMed ID: 31290993
[TBL] [Abstract][Full Text] [Related]
20. Combining Oncolytic Viruses With Cancer Immunotherapy: Establishing a New Generation of Cancer Treatment.
Shi T; Song X; Wang Y; Liu F; Wei J
Front Immunol; 2020; 11():683. PubMed ID: 32411132
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
